NIH-funded research Sbir 1 grant

Creating a test to detect hookworm infections in humans

Official title: Development of an ELISA for serosurveillance of human hookworm

Funded at Kephera Diagnostics, LLC · NIH-10815737 · Data updated 2026-11-12

This study is working on a new test to help doctors find hookworm infections more easily, especially in children and women in sub-Saharan Africa, so they can get the right treatment and improve their health.

Quick facts

Grant typeSbir 1 grant
Study typeNIH-funded research
Funding institutionKephera Diagnostics, LLC
NIH-funded
Lab location1 site (Framingham, UNITED STATES)
Project startApril 1, 2023
Project endMarch 31, 2026
Funding year2024
Award (this year)$300,000
NIH project number5R43AI174487-02
Project IDNIH-10815737 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are children and women of reproductive age living in regions where hookworm infections are common.

Less likely to help

Patients who do not live in endemic areas for hookworm infections or who are not within the targeted age groups may not benefit from this research.

What this research studies

This research focuses on developing a new ELISA (enzyme-linked immunosorbent assay) to improve the detection of hookworm infections, which are prevalent in sub-Saharan Africa and other regions. The study aims to provide a more sensitive and reliable method for identifying these infections compared to current techniques, which often miss cases. By enhancing detection capabilities, the research seeks to better understand the impact of hookworm on health, particularly in children and women of reproductive age, who are most affected by the associated malnutrition and anemia. The findings could lead to improved public health strategies and treatment options for affected populations.

Why it matters

Potential benefit: If successful, this research could lead to better detection and management of hookworm infections, ultimately improving health outcomes for affected individuals.

How similar studies have gone: Previous research has shown that improved diagnostic methods for infectious diseases can significantly enhance treatment outcomes, suggesting that this approach has the potential for success.

Where this research is happening

  • Kephera Diagnostics, LLC
    Framingham, United States
    Active

Researchers

  • Principal investigator: Levin, Andrew E. — Kephera Diagnostics, LLC
  • Study coordinator: Levin, Andrew E.

Related research

Other NIH-funded projects on the same topics.

  • Peptide-based Diagnostic Test for Sarcoidosis

    A new test using peptide-based ELISA is being developed to diagnose sarcoidosis, potentially reducing the need for invasive lung biopsies.

    NIH research Kephera Diagnostics, LLC · Framingham, UNITED STATES · NIH-11417199

  • Rapid bedside test for neurocysticercosis in adults with seizures

    A quick clinic test to detect brain tapeworm infection (neurocysticercosis) in adults who present with seizures.

    NIH research Kephera Diagnostics, LLC · Framingham, UNITED STATES · NIH-11382998

  • Finding new ways to diagnose neglected tropical diseases.

    This study is looking for new ways to quickly and accurately diagnose neglected tropical diseases caused by a parasite called T. cruzi, so that patients can get the right treatment sooner.

    NIH research Kephera Diagnostics, LLC · Framingham, UNITED STATES · NIH-11307400

  • Rapid diagnostic test for Strongyloides infection

    A quick, easy-to-use test is being developed to detect Strongyloides infections, helping people who may have returned from at-risk areas or who are immunocompromised.

    NIH research Kephera Diagnostics, LLC · Framingham, UNITED STATES · NIH-11256317

  • Creating a blood test for herpes simplex viruses 1 and 2.

    This study is working on a new blood test that can help find out if someone has been infected with the herpes virus, so that people can get better treatment and support for their condition.

    NIH research Kephera Diagnostics, LLC · Framingham, UNITED STATES · NIH-11203290

  • Single-step, more accurate blood test for Lyme disease

    This project is creating a single-step blood test that is easier to use and less likely to give false positives so people get faster, clearer Lyme diagnoses.

    NIH research Kephera Diagnostics, LLC · Framingham, UNITED STATES · NIH-11158727

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.